Taiwan: TIPO provides remarks on time limits in invalidation proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: TIPO provides remarks on time limits in invalidation proceedings

ales-krivec-zmzhcvivgbg-unsplash.jpg

Yen-Bin Gu of Saint Island Intellectual Property Group explains how TIPO has reacted to the regulations introduced to counter lengthy invalidation actions

Under the old Patent Act, a supplementary invalidation brief, evidence, a counter-statement, and/or amendment of claims could be filed at any time before Taiwan’s Intellectual Property Office (TIPO) issued a decision.

In order to prevent an invalidation action from dragging on for too long, TIPO has included a rigid timeframe in the new Patent Act that was implemented and enforced since last year. 

After taking stock of the situation brought about by the stringent time-constraint requirement over a year, TIPO has provided some remarks: 

1. The new stipulation that an invalidation petitioner must submit supplementary briefs and/or evidence within three months from the date that the invalidation action is filed, or within one month from the receipt of any notification from TIPO, has been and will be strictly observed. In this context, any supplementary evidential materials that are filed late would not be taken into account except if they are filed at the request of the responsible examiner to clarify the circumstances of the case.

2. Filing amendment of claims in an invalidation action is also restricted. The patentee is only allowed to conduct an amendment before a deadline designated by the examiner for submitting a counter-statement, a supplementary counter-statement or upon receipt of a notification from TIPO that there are lingering doubts to be cleared, or that the amendment filed with the counter-statement has been rejected. No time limit is imposed on the patentee only if the patent at issue is the subject of a merit lawsuit.

3. In the case that a counter-statement against an invalidation action is filed along with an amendment after a designated deadline, the contents of the counter-statement, filed prior to finalisation of the invalidation action, are to be considered. As to the amendment, it will be rejected for not being filed at an appropriate time as specified above. However, since the contents of the counter-statement filed by the patentee are drafted based on the amendment concurrently filed, the examiner will generally notify the patentee that the amendment not timely filed is rejected and the case will be examined based upon the granted claims as published. Upon receipt of such notification, the patentee may re-file the amendment and the examiner will examine it with cross-reference to the contents of the counter-statement as filed.

In view of the time limits prescribed in the Patent Act, either the invalidation petitioner or the patentee is placed under tight time pressure. It would be of much help if practitioners could assist their clients to collect useful evidential materials and develop winning strategies in the first place. 

Yen-Bin Gu

Partner

E: siiplo@mail.saint-island.com.tw

 

more from across site and SHARED ros bottom lb

More from across our site

Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Gift this article